Novo Nordisk Finally Catches Bid After FDA Warns Telehealth Companies

Novo Nordisk Finally Catches Bid After FDA Warns Telehealth Companies Novo Nordisk shares in Copenhagen finally caught a bid after the U.S. Food and Drug Administration issued 30 warning letters to telehealth companies for making false and misleading claims regarding compounded GLP-1 products (otherwise known as copycat GLP-1s) offered on their websites. FDA has warned 30 telehealth companies about misleading drug ads. Consumers should not be fooled into thinking that unapprove...

By Tyler Durden